BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 27/05/2026

FDA Withdraws Hearing Requests for Estrogen-Androgen Fixed-Combination Drug Products

The FDA has withdrawn all outstanding hearing requests for estrogen-androgen fixed-combination drug products, finding they are not effective for use under prescribed conditions, and prohibits interstate shipment of non-approved products.

Source: Federal Register — Health and Human ServicesOpen original release →